Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma ; volume:36 ; number:9 ; day:20 ; month:6 ; year:2022 ; pages:2165-2176 ; date:9.2022
Leukemia ; 36, Heft 9 (20.6.2022), 2165-2176, 9.2022
- Urheber
-
Thus, Yvonne J.
Eldering, Eric
Kater, Arnon P.
Spaargaren, Marcel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-022-01627-9
- URN
-
urn:nbn:de:101:1-2022111309341407210687
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thus, Yvonne J.
- Eldering, Eric
- Kater, Arnon P.
- Spaargaren, Marcel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Emerging therapies in mantle cell lymphoma
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib‐resistant non‐nodal leukemic mantle cell lymphoma
Extreme Events Contributing to Tipping Elements and Tipping Points
Tipping the Velvet
Democratic Tipping Points
Political Tipping Points
Tipping the velvet
Climate Tipping Points
Emerging therapies in mantle cell lymphoma
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib‐resistant non‐nodal leukemic mantle cell lymphoma
Extreme Events Contributing to Tipping Elements and Tipping Points
Tipping the Velvet
Democratic Tipping Points
Political Tipping Points
Tipping the velvet
Climate Tipping Points
Emerging therapies in mantle cell lymphoma
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib‐resistant non‐nodal leukemic mantle cell lymphoma
Extreme Events Contributing to Tipping Elements and Tipping Points
Tipping the Velvet
Democratic Tipping Points
Political Tipping Points
Tipping the velvet